Journal for ImmunoTherapy of Cancer: 1 (1)

Basic Tumor Immunology

Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells (23 September, 2013) Free
Anita Kumari, Ercan Cacan, Susanna F Greer, Charlie Garnett-Benson
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)- LLO immunotherapy
(29 August, 2013) Free
Mikayel Mkrtichyan, Namju Chong, Rasha Abu Eid, Anu Wallecha, Reshma Singh, John Rothman, Samir N Khleif
PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody (27 August, 2013) Free
Helena Escuin-Ordinas, Mark W Elliott, Mohammad Atefi, Michelle Lee, Charles Ng, Liu Wei, Begoña Comin-Anduix, Encarnacion Montecino-Rodriguez, Earl Avramis, Caius Radu, Leslie L Sharp, Antoni Ribas
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb (29 May, 2013) Free
Aizea Morales-Kastresana, Elena Catalán, Sandra Hervás-Stubbs, Asis Palazón, Arantza Azpilikueta, Elixabet Bolaños, Alberto Anel, Julián Pardo, Ignacio Melero

Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts (16 December, 2013) Free
Masasuke Ohno, Takayuki Ohkuri, Akemi Kosaka, Kuniaki Tanahashi, Carl H June, Atsushi Natsume, Hideho Okada
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma (18 November, 2013) Free
Jianda Yuan, Geoffrey Y Ku, Matthew Adamow, Zhenyu Mu, Sapna Tandon, Drew Hannaman, Paul Chapman, Gary Schwartz, Richard Carvajal, Katherine S Panageas, Alan N Houghton, Jedd D Wolchok
Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma (18 November, 2013) Free
Hadas Prag Naveh, Lazar Vujanovic, Lisa H Butterfield
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma (27 June, 2013) Free
Daniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, Mebea Aklilu, Daniel VT Catenacci, Blase N Polite, Cara Rosenbaum, Azadeh Namakydoust, Theodore Karrison, Thomas F Gajewski, Hedy L Kindler

Immune monitoring using the predictive power of immune profiles (27 June, 2013) Free
Michael P Gustafson, Yi Lin, Betsy LaPlant, Courtney J Liwski, Mary L Maas, Stacy C League, Philippe R Bauer, Roshini S Abraham, Matthew K Tollefson, Eugene D Kwon, Dennis A Gastineau, Allan B Dietz
Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination (29 May, 2013)
Jordan T Becker, Douglas G McNeel

Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012 (27 June, 2013) Free
Melek Erdinc Sunay, Francesco Marincola, Samir N Khleif, Samuel C Silverstein, Bernard A Fox, Jerome Galon, Leisha A Emens
Professional development session for early career scientists at SITC 2012 (27 June, 2013)
Christian M Capitini, William L Redmond, Kimberly A Shafer-Weaver
Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting (29 May, 2013)
David F Stroncek, Cornelis JM Melief, Luciano Castiello, Alessandra Cesano, Martin A Cheever, Sara Civini, Begonya Comin-Anduix, Thomas F Gajewski, Philip D Greenberg, Pawel Kalinski, Howard L Kaufman, Michael H Kershaw, Samir N Khleif, Francesco Marincola, William Merritt, David H Munn, Daniel J Powell, Nicholas P Restifo, Steven A Rosenberg, Raj K Puri, Howard Streicher, Aladar A Szalay, Cassian Yee, Laurence Zitvogel, Antoni Ribas

Statistical issues and challenges in immuno-oncology (21 October, 2013)
Tai-Tsang Chen
Rational combinations of immunotherapeutics that target discrete pathways (23 September, 2013)
Stefani Spranger, Thomas Gajewski
Immune evasion in acute myeloid leukemia: current concepts and future directions (27 August, 2013)
Ryan M Teague, Justin Kline
Primer on tumor immunology and cancer immunotherapy (29 July, 2013)
Timothy J Harris, Charles G Drake
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors (29 July, 2013)
Willem W Overwijk, Ena Wang, Francesco M Marincola, Hans-Georg Rammensee, Nicholas P Restifo, for the Organizing Committee of the 2013 SITC Workshop on Personalized Immunotherapy
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer (15 July, 2013) Free
Robert Wesolowski, Joseph Markowitz, William E Carson
Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation (29 May, 2013) Free
Ramjay S Vatsan, Peter F Bross, Ke Liu, Marc Theoret, Angelo R De Claro, Jinhua Lu, Whitney Helms, Brian Niland, Syed R Husain, Raj K Puri